CVS, UnitedHealth, Cigna Ask FTC's Khan to Disqualify Herself From Insulin Case
NEW YORK (Reuters) -CVS Health, UnitedHealth Group and Cigna have asked U.S. Federal Trade Commission chair Lina Khan and commissioners Rebecca Kelly Slaughter and Alvaro Bedoya to disqualify themselves from an FTC lawsuit that has accused the companies of unlawfully inflating insulin prices.
Whatever the outcome of the countering lawsuits, it will be a challenging period for PBMs, given the FTC's actions on alleged ...
CVS Caremark and Optum disputed the FTC's allegations. "CVS Caremark is proud of the work we have done to make insulin more affordable for all Americans with diabetes. To suggest anything ...
The FTC did not sue the three major makers of ... The drugmaker’s shares did not react on Friday afternoon. CVS Caremark said in its statement that any attempt to curtail pharmacy benefit ...
The Federal Trade Commission has sued CVS Caremark, Express Scripts and Optum Rx, alleging that they engage in "anticompetitive and unfair rebating practices” as it relates to insulin. One legal ...
CVS Caremark in a statement said it had worked ... Cigna Chief Legal Officer Andrea Nelson refuted the FTC's allegations and reiterated the role PBMs such as Express Scripts play in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback